Views & Analysis
Closed up of sandglass or hourglass on background of book

Long COVID but short on treatment options

With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the case with the creation of a treatment for Long COVID.


Verily taps Oncimmune tech for 'long COVID' study

Alphabet's Verily Life Science has contracted UK biotech Oncimmune to investigate autoantibodies in people who have developed long-lasting symptoms after COVID-19 infection, a condition kno